Organizer
Phenomenex
Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.
Tags
Consumables
Columns
Tips & Tricks
LinkedIn Logo

Strategies for Improving Chromatographic Resolution

RECORD | Already taken place Tu, 25.5.2021
This presentation will look at some of the solutions to modern day chromatographic challenges for polar compounds.
Go to the webinar
Pixabay/USA-Reiseblogger: Strategies for Improving Chromatographic Resolution
Pixabay/USA-Reiseblogger: Strategies for Improving Chromatographic Resolution

Modern drug candidates amongst other compounds present many challenges chromatographically, be that detection, resolution from a co-eluting impurity but one of the most common difficulties faced is the retention and resolution of polar compounds not amenable to typical C18 reversed phase conditions.

Many traditional reversed phase HPLC stationary phases do not provide adequate retention for many of the ever increasing number of polar compounds analyzed by HPLC. These compounds are often unretained in the void volume of the column or retention is so poor their peak shape is compromised or there is co-elution with other poorly retained peaks. Early eluting peaks also elute in an ion-suppression zone which is particular problem for people using LC-MS instruments.

This presentation will summarize the different approaches available outside of normal phase chromatography which is generally avoided by most labs due to poor robustness, incompatible solvents – especially for LC-MS and also the lack of efficiency with normal phase methods.

Phenomenex
LinkedIn Logo
 

Related content

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike